Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for ANIP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 375.87M
March 31, 2026 326.10M
December 31, 2025 294.75M
September 30, 2025 271.50M
June 30, 2025 223.55M
March 31, 2025 155.22M
December 31, 2024 151.20M
September 30, 2024 153.32M
June 30, 2024 247.05M
March 31, 2024 238.25M
December 31, 2023 221.12M
September 30, 2023 193.08M
June 30, 2023 161.71M
March 31, 2023 67.76M
December 31, 2022 53.23M
September 30, 2022 56.28M
June 30, 2022 63.38M
March 31, 2022 76.91M
December 31, 2021 100.30M
September 30, 2021 15.25M
June 30, 2021 24.26M
March 31, 2021 25.07M
December 31, 2020 7.864M
September 30, 2020 17.90M
June 30, 2020 27.70M
Date Value
March 31, 2020 20.41M
December 31, 2019 62.33M
September 30, 2019 59.67M
June 30, 2019 40.59M
March 31, 2019 38.23M
December 31, 2018 43.01M
September 30, 2018 44.14M
June 30, 2018 54.99M
March 31, 2018 51.97M
December 31, 2017 31.14M
September 30, 2017 18.03M
June 30, 2017 8.369M
March 31, 2017 10.83M
December 31, 2016 27.36M
September 30, 2016 16.16M
June 30, 2016 15.01M
March 31, 2016 77.75M
December 31, 2015 154.68M
September 30, 2015 150.91M
June 30, 2015 166.73M
March 31, 2015 165.56M
December 31, 2014 169.04M
September 30, 2014 35.05M
June 30, 2014 52.96M
March 31, 2014 51.37M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Viatris, Inc. 1.410B
Liquidia Corp. 284.18M
Elanco Animal Health, Inc. 530.00M
Harmony Biosciences Holdings, Inc. 667.79M
Corcept Therapeutics, Inc. 308.20M